Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322017PMC
http://dx.doi.org/10.1513/AnnalsATS.201806-401RLDOI Listing

Publication Analysis

Top Keywords

sarcoidosis-associated hospitalizations
4
hospitalizations united
4
united states
4
states 2002
4
2002 2012
4
sarcoidosis-associated
1
united
1
states
1
0
1
1
1

Similar Publications

Introduction: Sarcoidosis is an inflammatory disease characterized by granulomas, the etiology of which remains unclear. This study examines sarcoidosis-related mortality trends in the United States from 1999 to 2020, with a focus on disparities pertaining to patient sex, geographical location, and urbanization status.

Methods: We analyzed death certificate data from the CDC WONDER database, using ICD-10 code D86.

View Article and Find Full Text PDF

Generalized sarcoidosis associated with hypertrophic osteopathy in a Standardbred racehorse.

J Equine Vet Sci

January 2025

Department of Functional Sciences, Equine Division, Sports Medicine Section, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium. Electronic address:

Article Synopsis
  • A Standardbred racehorse presented with exercise intolerance, weight loss, fever, and facial deformity, leading to diagnostic imaging revealing soft tissue swelling and periostitis.
  • Radiological findings indicated bilateral periostitis in limbs, alongside skin lesions diagnosed as granulomatous dermatitis, suggesting equine sarcoidosis.
  • The horse was euthanized after a rapid health decline, with post-mortem findings confirming generalized equine sarcoidosis and the detection of equine herpesvirus 5 DNA.
View Article and Find Full Text PDF

Small fiber neuropathy is a common complication in patients with sarcoidosis and its prevalence is estimated at 40-86%. The underlying mechanism influences the presentation of small fiber neuropathy. For example, patients with metabolic diseases are often associated with a classic length-dependent small fiber neuropathy pattern, while patients with inflammatory diseases are more often present with a non-length-dependent small fiber neuropathy.

View Article and Find Full Text PDF

Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis.

Br J Ophthalmol

December 2024

Department of Internal Medicine and Clinical Immunology, Centre National de Références Maladies Autoimmunes et Systémiques Rares, Centre National de Références Maladies Autoinflammatoires Rares et Amylose Inflammatoire and INSERM, UMR S 959, Immunology- Immunopathology-Immunotherapy, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.

Aims: To compare the safety and efficacy of methotrexate (MTX), mycophenolate mofetil (MMF) and azathioprine (AZA) in non-anterior sarcoidosis-associated uveitis.

Methods: Retrospective study including non-anterior sarcoidosis-associated uveitis according to the revised International Workshop on Ocular Sarcoidosis criteria. The primary outcome was defined as the median time to relapse or occurrence of serious adverse events leading to treatment discontinuation.

View Article and Find Full Text PDF

Purpose: This study aims to explore the potential subgroups of sarcoidosis-associated uveitis (SAU) within a multicenter cohort of uveitis participants.

Design: Cross-sectional study.

Participants: A cohort of 826 uveitis patients from a uveitis registry from 19 clinical centers in 12 countries between January 2011 and April 2015.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!